|
Volumn 23, Issue 6 SUPPL. 14, 1996, Pages 56-62
|
Prostate cancer treatment strategies based on tumor-specific biological principles: Future directions
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE;
ANGIOGENESIS INHIBITOR;
ANTIMETASTATIC AGENT;
ARYLBUTYRIC ACID DERIVATIVE;
CANCER VACCINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
IMMUNOMODULATING AGENT;
MARIMISTAT;
METALLOPROTEINASE INHIBITOR;
RETINOID;
ROQUINIMEX;
SURAMIN;
THALIDOMIDE;
THAPSIGARGIN;
TOPOTECAN;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
APOPTOSIS;
CANCER IMMUNOTHERAPY;
CANCER RADIOTHERAPY;
CELL DIFFERENTIATION;
CONFERENCE PAPER;
COST CONTROL;
GENE THERAPY;
HUMAN;
IMMUNOMODULATION;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BIOLOGICAL RESPONSE MODIFIERS;
GENE THERAPY;
HUMANS;
IMMUNOTHERAPY;
MALE;
MEDICAL ONCOLOGY;
NEOPLASMS, HORMONE-DEPENDENT;
NEOVASCULARIZATION, PHYSIOLOGIC;
PALLIATIVE CARE;
PROSTATIC NEOPLASMS;
|
EID: 0030471103
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (16)
|
References (41)
|